Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO)
暂无分享,去创建一个
H. Harputluoglu | A. Sevinç | I. Turker | S. Buyukberber | B. Cetin | A. Ulaş | U. Coşkun | M. Benekli | F. Dane | C. Boruban | Burçak Yılmaz | V. Berk | M. Kaplan | B. Oksuzoglu | D. Uncu | D. Koca | L. Koral